Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT07186699
- Status
- Recruiting
Conditions
- Lung Non-Small Cell Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.
Key Dates
- Start date
- Sep 29, 2025
- Status verified
- Mar 2026
- Primary completion
- Sep 12, 2027
- Completion
- Sep 12, 2028
Study Design
- Enrollment
- 45 participants (estimated)
Arms
- Arm: ObservationalPatients participate in a semi-structured interview and may participate in a follow-up focus group interview in which preliminary findings are shared and feedback is elicited on study.
Primary Outcome Measure
Thematic saturation [ Time Frame: Up to 3 years ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Los Angeles General Medical Center | Los Angeles | California | 90033 | Brooks V. Udelsman (PRINCIPAL_INVESTIGATOR) |
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Brooks V. Udelsman (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
Related Studies
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])PHASE3 · Recruiting · National Cancer Institute (NCI) · Anchorage, Alaska
- Phase II Trial of Lung ChemoemobolizationPHASE2 · Recruiting · City of Hope Medical Center · Duarte, California
- Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell CarcinomaPHASE2 · Recruiting · City of Hope Medical Center · Duarte, California
- Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung CarcinomaPHASE2 · Recruiting · City of Hope Medical Center · Duarte, California